The company manufactures and sells cotton hosiery, undergarments, and casual wear for men, women, and children under brands like Jet and Lycot, primarily serving a retail network in Uttar Pradesh.
While management claims a 45-50% regional market share, the financial results show a decade-low profitability and negative revenue growth, suggesting no durable brand power or cost advantage. Low ROCE and razor-thin net margins contradict the narrative of a strong competitive position.
Capital is largely tied up in stagnant inventory and aging receivables rather than productive reinvestment. The company has avoided dividends to 'plough back' profits, yet these retained earnings have failed to generate incremental returns, evidenced by a 39% EPS decline.
The company's collapse was precipitated by the realization that the reported assets were largely illusory. The long-overdue receivables, some aging over three years, were eventually written off as uncollectible, wiping out the thin equity base. Simultaneously, the stagnant inventory, which auditors could not physically verify, proved to be obsolete or non-existent. As the interest coverage ratio dipped below one, the company defaulted on its obligations, while the ongoing legal battles regarding mismanagement paralyzed the board, leading to a total loss of creditor confidence and a liquidity trap.
RichFakir rates Jet Knitwears Ltd's business quality as poor — 31/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Jet Knitwears Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Jet Knitwears Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Jet Knitwears Ltd's fair value is about ₹14 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →